Sopharma Overview

  • Founded
  • 1933
Founded
  • Status
  • Public
  • Employees
  • 5,099
Employees
  • Stock Symbol
  • SFA
Stock Symbol
  • Investments
  • 21
  • Share Price
  • $2.03
  • (As of Thursday Closing)

Sopharma General Information

Description

Sopharma AD-Sofia is a Bulgaria based producer, exporter, and distributor of pharmaceutical products. It is engaged in the production of pharmaceutical products including medicines, primarily generics, herbal-based substances and food supplements. It is also focused on the distribution of pharmaceuticals like medical supplies, sanitary materials, vitamins, food supplements and cosmetics. The company operates in Bulgaria and internationally.

Contact Information

Website
www.sopharmagroup.com
Ownership Status
Publicly Held
Financing Status
Corporation
Primary Industry
Pharmaceuticals
Stock Exchange
XBUL
Primary Office
  • 16 Iliensko shose Street
  • Sofia, 1220
  • Bulgaria
+359 02 000 0000
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Sopharma Stock Performance

(As of Thursday Closing)

Stock Price Previous Close 52 wk Range Market Cap Shares Average Volume EPS
$2.03 $2.05 $1.35 - $2.17 $255M 126M 26.1K $0.58

Sopharma Financials Summary

In Thousands,
USD 		TTM 30-Sep-2020 FY 2019 31-Dec-2019 FY 2018 31-Dec-2018 FY 2017 31-Dec-2017
EV 450,398 470,959 438,697 481,009
Revenue 783,966 730,853 708,679 585,105
EBITDA 61,368 78,719 43,501 48,847
Net Income 42,805 49,610 17,034 23,009
Total Assets 707,483 670,572 588,981 599,668
Total Debt 219,546 219,237 176,320 160,438
Public Fundamental Data provided by Morningstar, Inc. disclaimer

Sopharma Executive Team (2)

Name Title Board Seat Contact Info
Ognian Donev Ph.D Chief Executive Officer, Chairman of the Board of Directors and Executive Director
Boris Borisov Chief Financial Officer
To view Sopharma’s complete executive team members history, request access »

Sopharma Board Members (1)

Name Representing Role Since
000000 00000 00.0 Sopharma Chief Executive Officer, Chairman of the Board of Directors and Executive Director 000 0000
To view Sopharma’s complete board members history, request access »

Sopharma Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %ile
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Sopharma Investments & Acquisitions (21)

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
00000000 19-Sep-2017 000000000 00000000 Pharmaceuticals
000000 09-Aug-2017 000000000000000000 Pharmaceuticals
00000000 21-Jul-2017 000000000000000000 Drug Discovery
000 000000 0000000 18-Apr-2017 000000000000000000 Distributors (Healthcare)
Unipharm 01-Dec-2016 Merger/Acquisition Pharmaceuticals
You’re viewing 5 of 21 investments and acquisitions. Get the full list »

Ready to get started?

Request a free trial

Sopharma Subsidiaries (6)

Company Name Industry Location Founded
Aromania Drug Discovery Sofia, Bulgaria 2015
00000000 Pharmaceuticals Sofia, Bulgaria 0000
0000 Acquirer Riga, Latvia 0000
000000 Pharmaceuticals Sofia, Bulgaria 0000
00000000 Pharmaceuticals Uman, Ukraine 0000
You’re viewing 5 of 6 subsidiaries. Get the full list »

Sopharma Exits (2)

Company Name Exit Date Exit Type Exit Size Status Buyers
0000000 0 000000 31-Mar-2008 000000000000000000 Completed
  • 00000000
Sopharma Zdrovit 27-Sep-2007 Joint Venture Completed
  • 2 buyers
To view Sopharma’s complete exits history, request access »